Industry
Siena Biotech S.p.A.
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 4 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 1
3(75.0%)
Phase 2
1(25.0%)
4Total
Phase 1(3)
Phase 2(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT01521585Phase 2Completed
A Phase II Safety and Tolerability Study With SEN0014196
Role: lead
NCT01485952Phase 1Completed
An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196
Role: lead
NCT01485965Phase 1Completed
A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease
Role: lead
NCT01521832Phase 1Completed
Escalating Dose Study in Healthy Volunteers With SEN0014196
Role: lead
All 4 trials loaded